Ankit Mahadevia Insider Trading $SPRO Spero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ankit Mahadevia.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ankit Mahadevia. Ankit Mahadevia is CEO and President in Spero Therapeutics, Inc. ($SPRO) and See Remarks in Spero Therapeutics, Inc. ($SPRO).
Ankit Mahadevia in Spero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ankit Mahadevia: CEO and President, See Remarks
Holdings: 67,954 shares
Latest Transaction: Feb 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ankit Mahadevia in Spero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | A | 19.18 | 179,319 | 3,439,338 | 179,319 | |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 7,370 | 43,483 | 494,809 | |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 2,137 | 12,608 | 502,179 | |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.43 | 7,370 | 106,335 | 65,817 | 73.2 K to 65.8 K (-10.07 %) |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 7,370 | 43,483 | 73,187 | 65.8 K to 73.2 K (+11.20 %) |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.27 | 2,137 | 30,490 | 65,817 | 68 K to 65.8 K (-3.14 %) |
| Nov 05 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 2,137 | 12,608 | 67,954 | 65.8 K to 68 K (+3.25 %) |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 20 | 118 | 504,316 | |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.25 | 20 | 285 | 65,817 | 65.8 K to 65.8 K (-0.03 %) |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 20 | 118 | 65,837 | 65.8 K to 65.8 K (+0.03 %) |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 774 | 4,567 | 518,808 | |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.25 | 774 | 11,030 | 65,817 | 66.6 K to 65.8 K (-1.16 %) |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 774 | 4,567 | 66,591 | 65.8 K to 66.6 K (+1.18 %) |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 774 | 4,567 | 518,808 | |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.25 | 774 | 11,030 | 65,817 | 66.6 K to 65.8 K (-1.16 %) |
| Sep 10 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 774 | 4,567 | 66,591 | 65.8 K to 66.6 K (+1.18 %) |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 2,293 | 13,529 | 519,582 | |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 754 | 4,449 | 521,875 | |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.31 | 2,293 | 32,807 | 65,817 | 68.1 K to 65.8 K (-3.37 %) |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 2,293 | 13,529 | 68,110 | 65.8 K to 68.1 K (+3.48 %) |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.25 | 754 | 10,745 | 65,817 | 66.6 K to 65.8 K (-1.13 %) |
| Jul 09 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 754 | 4,449 | 66,571 | 65.8 K to 66.6 K (+1.15 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 2,642 | 15,588 | 522,629 | |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 3,880 | 22,892 | 525,271 | |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 8,045 | 47,466 | 529,151 | |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | M | 5.90 | 2,613 | 15,417 | 537,196 | |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.25 | 2,642 | 37,650 | 65,817 | 68.5 K to 65.8 K (-3.86 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 2,642 | 15,588 | 68,459 | 65.8 K to 68.5 K (+4.01 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.28 | 3,880 | 55,420 | 65,817 | 69.7 K to 65.8 K (-5.57 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 3,880 | 22,892 | 69,697 | 65.8 K to 69.7 K (+5.90 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.33 | 8,045 | 115,264 | 65,817 | 73.9 K to 65.8 K (-10.89 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 8,045 | 47,466 | 73,862 | 65.8 K to 73.9 K (+12.22 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Sell | S | 14.30 | 2,613 | 37,365 | 65,817 | 68.4 K to 65.8 K (-3.82 %) |
| Jun 29 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Buy | M | 5.90 | 2,613 | 15,417 | 68,430 | 65.8 K to 68.4 K (+3.97 %) |
| Feb 03 2020 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | A | 9.34 | 180,000 | 1,681,200 | 180,000 | |
| Jan 02 2019 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | CEO and President | Option Exercise | A | 6.26 | 180,000 | 1,126,800 | 180,000 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |
| Dec 15 2017 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | A | 11.63 | 125,079 | 1,454,669 | 125,079 |
Page: 1